(Bloomberg) --Bright Health Group Inc. shares began trading on the New York Stock Exchange Thursday, the latest issue to test investors’ appetite for new health-care companies that have yet to show profit but are aiming for high growth.
The Minneapolis-based health insurer raised about $925 million on Wednesday, selling 51.4 million shares for $18 after marketing them for $20 to $23 apiece. Trading under the ticker symbol BHG, the shares fell 5.2% to $17.06 at 12:36 p.m. in New York.
Bright’s market debut caps a string of public listings of new health-care businesses, including insurers and primary-care companies. At least seven have gone public through IPOs or mergers with blank-check firms -- often called special purpose acquisition companies, or SPACs -- in the first half of 2021. Their combined market value: more than $46 billion.
Most are not yet profitable, and few are even projecting positive adjusted earnings before interest, taxes, depreciation and amortization for 2021, according to data compiled by Bloomberg News. The central question facing these companies is whether they can grow and eventually turn profits that justify their valuations. They also face execution risks in the complex, highly regulated health-care industry.
“We’re relentlessly focused on the consumer, and we want a high-performing care-delivery model,” Bright Chief Executive Officer G. Mike Mikan said in an interview Thursday.
Bright is addressing a broader market than some other companies, the CEO said.
“Our focus is really on serving all consumers,” he said. “It’s very different than a lot of our other competitors who are focused on one part of the health care system.”
Bright initially
Bright made several acquisitions in the months before it filed to go public, collecting medical groups, health plans and a telehealth company. It will be up to the management team to stitch them together while steering Bright through its first quarters as a public company.
Some signs of growing pains are evident in Bright’s Securities and Exchange Commission
Investors’ willingness to back this crop of companies is a bet that they can grow and eventually profit in the $4 trillion American health-care market. The industry includes some of the largest and most sophisticated companies in the U.S., giants like Anthem Inc. and UnitedHealth Group Inc.
Bright’s chairman and co-founder, Robert Sheehy, is a veteran of UnitedHealth who led the insurance business there. He co-founded Bright in 2015, shortly after the Affordable Care Act created new state markets for individual health plans. Bright’s strategy is to partner with select health systems in each market, rather than offer broad networks, and use technology to help patients navigate care.
Sheehy led the company for five years, until Mikan, another UnitedHealth veteran, took over as CEO last year. Bright had about 2,000 employees as of April. Its venture capital backers, including New Enterprise Associates and Bessemer Venture Partners, invested more than $1.5 billlion since 2016, and stand to gain in the IPO.
The company
The
Like larger rivals including UnitedHealth and Humana Inc., Bright is also expanding directly into care delivery. The company has acquired or taken controlling stakes in physician clinics in Florida, a physician-led New Mexico health plan and a telehealth company called Zipnosis.
Through such acquisitions, it created a unit last year called NeueHealth that Bright’s prospectus says “will become increasingly important to our business and prospects” going forward. NeueHealth provided just 2% of revenue last year and about 6% in the first quarter.